An avirulent mutant of rabies virus is unable to infect motoneurons in vivo and in vitro

Journal of Virology

Volumn 72, Issue 1, 1998, Pages 273-278

  Coulon, Patrice ^a   Ternaux, Jean Pierre ^a   Flamand, Anne ^a   Tuffereau, Christine ^a  

^a CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

MONOCLONAL ANTIBODY; VIRUS ANTIGEN; VIRUS GLYCOPROTEIN;

AMINO ACID SUBSTITUTION; ANIMAL CELL; ANTIBODY SPECIFICITY; ANTIGENICITY; ARTICLE; CENTRAL NERVOUS SYSTEM INFECTION; EMBRYO; MOTONEURON; NERVE CELL CULTURE; NEUROBLASTOMA CELL; NONHUMAN; PRIORITY JOURNAL; RABIES; RABIES VIRUS; RAT; SPINAL CORD; SPINAL GANGLION; VIRUS INFECTION; VIRUS MUTANT;

EID: 0031974476     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.72.1.273-278.1998     Document Type: Article

References (34)

1. Anilionis, A., W. H. Wunner, and P. J. Curtis. 1981. Structure of the glycoprotein gene in rabies virus. Nature (London) 294:275-278.
2. Bai, X. H., C. K. Warner, and M. Fekadu. 1993. Comparisons of nucleotide and deduced amino acid sequences of the glycoprotein genes of a Chinese street strain (CGX89-1) and a Chinese vaccine strain (3aG) of rabies virus. Virus. Res. 27:101-112.
3. Bataillé, S., P. Portalier, P. Coulon, and J. P. Ternaux. Influence of acetylcholinesterase on embryonic spinal rat motoneuron growth in culture: a quantitative morphometric study. Eur. J. Neurosci., in press.
4. Benmansour, A., M. Brahimi, C. Tuffereau, P. Coulon, F. Lafay, and A. Flamand. 1992. Rapid sequence evolution of street rabies glycoprotein is related to the highly heterogeneous nature of the viral population. Virology 187:33-45.
5. Benmansour, A., H. Leblois, P. Coulon, C. Tuffereau, Y. Gaudin, A. Flamand, and F. Lafay. 1991. Antigenicity of rabies virus glycoprotein. J. Virol. 65:4198-4203.
6. Conzelmann, K.-K., J. H. Cox, L. G. Schneider, and H.-J. Thiel. 1990. Molecular cloning and complete nucleotide sequence of the attenuated rabies virus SAD B19. Virology 175:485-499.
7. Coulon, P., C. Derbin, P. Kucera, F. Lafay, C. Préhaud, and A. Flamand. 1989. Invasion of the peripheral nervous systems of adult mice by the CVS strain of rabies virus and its avirulent derivative AvO1. J. Virol. 63:3550-3554.
8. Coulon, P., F. Lafay, C. Tuffereau, and A. Flamand. 1994. The molecular basis for altered pathogenicity of lyssavirus variants. Curr. Top. Microbiol. Immunol. 187:69-84.
9. Dietzschold, B., W. H. Wunner, T. J. Wiktor, A. D. Lopes, M. Lafon, C. L. Smith, and H. Koprowski. 1983. Characterization of an antigenic determinant of the glycoprotein that correlates with pathogenicity of rabies virus. Proc. Natl. Acad. Sci. USA 80:70-74.
10. Gaudin, Y., R. W. H. Ruigrok, C. Tuffereau, M. Knossow, and A. Flamand. 1992. Rabies virus glycoprotein is a trimer. Virology 187:627-632.
11. Jackson, A. C. 1991. Biological basis of rabies virus neurovirulence in mice: comparative pathogenesis study using the immunoperoxidase technique. J. Virol. 65:537-540.
12. Lafay, F., J. Bénéjean, C. Tuffereau, A. Flamand, and P. Coulon. 1994. Vaccination against rabies - construction and characterization of SAG2, a double avirulent derivative of SAD(Bern). Vaccine 12:317-320.
13. Lafay, F., P. Coulon, L. Astic, D. Saucier, D. Riche, A. Holley, and A. Flamand. 1991. Spread of the CVS strain of rabies virus and of the avirulent mutant AvO1 along the olfactory pathways of the mouse after intranasal inoculation. Virology 183:320-330.
14. Lentz, T. L., R. J. J. Benson, D. Klimovicz, P. T. Wilson, and E. Hawrot. 1986. Binding of rabies virus to purified Torpedo acetylcholine receptor. Mol. Brain Res. 1:211-219.
15. Morimoto, K., M. Patel, S. Corisdeo, D. C. Hooper, Z. F. Fu, C. E. Rupprecht, H. Koprowski, and B. Dietzschold. 1996. Characterization of a unique variant of bat rabies virus responsible for newly emerging human cases in North America. Proc. Natl. Acad. Sci. USA 93:5653-5658.
16. Murphy, F. A., S. P. Bauer, A. K. Harrison, and W. C. Winn, Jr. 1973. Comparative pathogenesis of rabies and rabies-like viruses: viral infection and transit from inoculation site to the central nervous system. Lab. Invest. 28:361-376.
17. Nadindavis, S. A., G. A. Casey, and A. I. Wandeler. 1994. A molecular epidemiological study of rabies virus in central Ontario and western Quebec. J. Gen. Virol. 75:2575-2583.
18. Nelson, P., C. Clifford, and M. Nirenberg. 1976. Synapse formation between clonal neuroblastoma X glioma hybrid cells and striated muscle cells. Proc. Natl. Acad. Sci. USA 73:123-127.
19. Raux, H., P. Coulon, F. Lafay, and A. Flamand. 1995. Monoclonal antibodies which recognize the acidic configuration of the rabies glycoprotein at the surface of the virion can be neutralizing. Virology 210:400-408.
20. Reagan, K. J., and W. H. Wunner. 1985. Rabies virus interaction with various cell lines is independent of the acetylcholine receptor. Arch. Virol. 84:277-282.
21. Schnell, M. J., T. Mebatsion, and K. K. Conzelmann. 1994. Infectious rabies viruses from cloned cDNA. EMBO J. 13:4195-4203.
22. Seif, I., P. Coulon, P. E. Rollin, and A. Flamand. 1985. Rabies virulence: effect on pathogenicity and sequence characterization of rabies virus mutations affecting antigenic site III of the glycoprotein. J. Virol. 53:926-934.
23. Superti, F., B. Hauttecoeur, M. J. Morelec, P. Goldoni, B. Bizzini, and H. Tsiang. 1986. Involvement of gangliosides in rabies virus infection. J. Gen. Virol. 67:47-56.
24. Superti, F., L. Seganti, H. Tsiang, and N. Orsi. 1984. Role of phospholipids in rhabdovirus attachment to CER cells. Arch. Virol. 81:321-328.
25. Ternaux, J.-P., and P. Portalier. 1993. Culture of hypoglossal cells dissociated from foetal and new-born rats. J. Neurosci. Methods 49:33-47.
26. Tolson, N. D., K. M. Charlton, R. B. Stewart, G. A. Casey, W. A. Webster, K. MacKenzie, J. B. Campbell, and K. F. Lawson. 1990. Mutants of rabies virus in skunks: immune response and pathogenicity. Can. J. Vet. Res. 54:178-183.
27. Tordo, N., H. Bourhy, S. Sather, and R. Ollo. 1993. Structure and expression in the baculovirus of the Mokola virus glycoprotein: an efficient recombinant vaccine. Virology 194:59-69.
28. Tordo, N., O. Poch, A. Ermine, G. Keith, and F. Rougeon. 1986. Walking along the rabies genome: is the large G-L intergenic region a remnant gene? Proc. Natl. Acad. Sci. USA 83:3914-3918.
29. Tuffereau, C., H. Leblois, J. Bénéjean, P. Coulon, F. Lafay, and A. Flamand. 1989. Arginine or lysine in position 333 of ERA and CVS glycoprotein is necessary for rabies virulence in mice. Virology 172:206-212.
30. Tuffereau, C., J. Bénéjean, A.-M. Roque Alfonso, A. Flamand, and M. K. Fishman. Neuronal cell surface molecules mediate specific binding to rabies virus glycoprotein expressed by a recombinant baculovirus on the surfaces of lepidoptera cells. J. Virol., in press.
31. Wagner, R. R., and J. K. Rose. 1996. Rhabdoviridae: the viruses and their replication, p. 1121-1135. In B. N. Fields, D. M. Knipe, and P. M. Howley (ed.), Fields virology. Lippincott-Raven, Philadelphia, Pa.
32. Wunner, W. H., B. Dietzschold, C. L. Smith, M. Lafon, and E. Golub. 1985. Antigenic variants of CVS rabies virus with altered glycosylation sites. Virology 140:1-12.
33. Wunner, W. H., K. J. Reagan, and H. Koprowski. 1984. Characterization of saturable binding sites for rabies virus. J. Virol. 50:691-697.
34. Yelverton, E., S. Norton, J. F. Obijeski, and D. V. Goeddel. 1983. Rabies virus glycoprotein analogs: biosynthesis in Escherichia coli. Science 219:614-620.